News | August 08, 2023
Surging demand for Korean pharma in 2023 ahead of CPHI Korea
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
Medica Superspecialty Hospital becomes the first private hospital in Eastern India to collaborate with UNICEF for breastfeeding workshop
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Marks the World Head & Neck Cancer Day at the OCTF Conference
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Subscribe To Our Newsletter & Stay Updated
